TARGET N V BIOTECH Insider Trading $ESPR Esperion Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for TARGET N V BIOTECH.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of TARGET N V BIOTECH. TARGET N V BIOTECH is 10% Owner in Monogram Biosciences, Inc. ($VLGC) and 10% Owner in Molecular Templates, Inc. ($MTEM) and 10% Owner in MACROGENICS INC ($MGNX) and 10% Owner in Radius Health, Inc. ($RDUS) and 10% Owner in Esperion Therapeutics, Inc. ($ESPR) and 10% Owner in Cidara Therapeutics, Inc. ($CDTX).

TARGET N V BIOTECH in Esperion Therapeutics, Inc.

Trading Symbol: ESPR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of TARGET N V BIOTECH: 10% Owner
Holdings: 4,097,964 shares
Current Value: $72,370,044
Latest Transaction: May 07 2021
$ESPR Market Capitalization: $454.22M
$ESPR Previous Close: $17.66

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of TARGET N V BIOTECH in Esperion Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, CDTX, ESPR, MGNX, MTEM, VLGC, RDUS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 07 2021ESPREsperion Therapeut ...BIOTECH TARGET N V10% OwnerBuyP20.5780,0001,645,6324,177,9644.1 M to 4.2 M (+1.95 %)
May 07 2021ESPREsperion Therapeut ...BIOTECH TARGET N V10% OwnerBuyP20.02150,0003,002,8504,097,9643.9 M to 4.1 M (+3.80 %)
Nov 04 2020ESPREsperion Therapeut ...BIOTECH TARGET N V10% OwnerBuyP25.31200,0005,062,1203,947,9643.7 M to 3.9 M (+5.34 %)
Jan 27 2020ESPREsperion Therapeut ...BIOTECH TARGET N V10% OwnerBuyP52.1220,0001,042,3983,747,9643.7 M to 3.7 M (+0.54 %)
Nov 08 2019ESPREsperion Therapeut ...BIOTECH TARGET N V10% OwnerBuyP37.3075,0002,797,5603,727,9643.7 M to 3.7 M (+2.05 %)
Sep 06 2019ESPREsperion Therapeut ...BIOTECH TARGET N V10% OwnerBuyP33.7880,0002,702,2083,652,9643.6 M to 3.7 M (+2.24 %)
Jul 25 2019ESPREsperion Therapeut ...BIOTECH TARGET N V10% OwnerBuyP42.6550,0002,132,5653,572,9643.5 M to 3.6 M (+1.42 %)
Mar 15 2019ESPREsperion Therapeut ...BIOTECH TARGET N V10% OwnerBuyP49.8950,0002,494,3553,522,9643.5 M to 3.5 M (+1.44 %)
Jan 07 2019ESPREsperion Therapeut ...BIOTECH TARGET N V10% OwnerBuyP41.2980,0003,303,2563,472,9643.4 M to 3.5 M (+2.36 %)
Dec 26 2018ESPREsperion Therapeut ...BIOTECH TARGET N V10% OwnerBuyP39.9150,0001,995,7253,392,9643.3 M to 3.4 M (+1.50 %)
Dec 19 2018ESPREsperion Therapeut ...BIOTECH TARGET N V10% OwnerBuyP47.7360,0002,864,0703,342,9643.3 M to 3.3 M (+1.83 %)
Aug 06 2018ESPREsperion Therapeut ...BIOTECH TARGET N V10% OwnerBuyP46.1450,0002,306,9703,282,9643.2 M to 3.3 M (+1.55 %)
Jul 13 2018ESPREsperion Therapeut ...BIOTECH TARGET N V10% OwnerBuyP41.7750,0002,088,3003,232,9643.2 M to 3.2 M (+1.57 %)
Jul 03 2018ESPREsperion Therapeut ...BIOTECH TARGET N V10% OwnerBuyP39.4850,0001,973,8053,182,9643.1 M to 3.2 M (+1.60 %)
Jun 25 2018ESPREsperion Therapeut ...BIOTECH TARGET N V10% OwnerBuyP38.5760,0002,314,2243,132,9643.1 M to 3.1 M (+1.95 %)
Jun 11 2018ESPREsperion Therapeut ...BIOTECH TARGET N V10% OwnerBuyP37.7960,0002,267,2923,072,9643 M to 3.1 M (+1.99 %)
Jun 07 2018ESPREsperion Therapeut ...BIOTECH TARGET N V10% OwnerBuyP38.4760,0002,308,4403,012,9643 M to 3 M (+2.03 %)
May 22 2018ESPREsperion Therapeut ...BIOTECH TARGET N V10% OwnerBuyP38.7780,0003,101,7602,952,9642.9 M to 3 M (+2.78 %)
May 22 2018ESPREsperion Therapeut ...BIOTECH TARGET N V10% OwnerBuyP42.2450,0002,112,0102,872,9642.8 M to 2.9 M (+1.77 %)

Page:   1